TYMS, MTHFR, p53 and MDR1 gene polymorphisms in breast cancer patients treated with adjuvant therapy

被引：7
|
作者：
Alberto Henriquez-Hernandez, Luis [1 ]
Fernandez Perez, Leandro [1 ]
Gonzalez Hernandez, Ana [2 ]
Cabrera de Leon, Antonio [2 ]
Diaz-Chico, Bonifacio [3 ]
Murias Rosales, A. [4 ]
机构：
[1] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria 35016, Spain
[2] Hosp Univ La Candelaria, Hosp La Candelaria, Res Unit, Santa Cruz de Tenerife 38010, Spain
[3] Univ Las Palmas Gran Canaria, Physiol Biochem & Mol Biol Dept, Las Palmas Gran Canaria 35016, Spain
[4] Hosp Univ Insular Gran Canaria, Med Oncol Serv, Las Palmas Gran Canaria 35016, Spain
来源：
CANCER EPIDEMIOLOGY | 2010年 / 34卷 / 04期
关键词：
Breast cancer; Adjuvant chemotherapy; Multifocal tumour; Polymorphism; PCR-RFLP; Risk factors; MTHFR; THYMIDYLATE SYNTHASE GENE; METHYLENETETRAHYDROFOLATE REDUCTASE; RISK; FOLATE; DISEASE; METABOLISM; EXPRESSION; GENOTYPE; C3435T; DIET;
D O I：
10.1016/j.canep.2010.03.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose. The distribution of TSER (TYMS), C677T (MTHFR), Arg72Pro (p53) and C3435T (MDR1) gene polymorphisms was investigated in 80 consecutive breast cancer patients treated with adjuvant chemotherapy Results Observed allelic frequencies were TSER, (2)0 55 and (3)0 45, MTHFR C677T, (C) 065 and (T) 035: p53 Arg72Pro, (Arg) 076 and (Pro) 024, MDR1 C3435T, (C) 051 and (T) 0.49 MTHFR C677T was found to be a strong predictor of the presence of multifocal tumour (odds ratio, 4 1, 95% CI, 1 1-15 7, P = 0 035) Conclusion Our data indicate that breast cancer patients with the C/C variant may Present multifocal tumour most frequently (C) 2010 Elsevier Ltd All rights reserved
引用
下载
收藏
页码：490 / 493
页数：4
相关论文
共 50 条
  • [1] Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy
    Alberto Henriquez-Hernandez, Luis
    Murias-Rosales, Adolfo
    Gonzalez-Hernandez, Ana
    Cabrera de Leon, Antonio
    Diaz-Chico, Nicolas
    Fernandez-Perez, Leandro
    CANCER EPIDEMIOLOGY, 2010, 34 (05) : 634 - 638
  • [2] Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: A case-control study
    Henriquez-Hernandez, L. A.
    Murias Rosales, A.
    Hernandez Gonzalez, A.
    Cabrera De Leon, A.
    Diaz-Chico, B. N.
    Mori De Santiago, M.
    Fernandez Perez, L.
    ONCOLOGY REPORTS, 2009, 22 (06) : 1425 - 1433
  • [3] P53, MDR1 and SPF prognostic relevance in breast cancer
    Vielh, P
    Pouillart, P
    Klijanienko, J
    Fourquet, A
    Chevillard, S
    LABORATORY INVESTIGATION, 1998, 78 (01) : 29A - 29A
  • [4] p53, MDR1 and SPF prognostic relevance in breast cancer
    Vielh, P
    Pouillart, P
    Klijanienko, J
    Fourquet, A
    Chevillard, S
    MODERN PATHOLOGY, 1998, 11 (01) : 29A - 29A
  • [5] THE INFLUENCE OF TYMS AND MTHFR GENE POLYMORPHISMS ON TOXICITY AND RESPONSE IN BREAST CANCER PATIENTS TREATED WITH 5-FLUOROURACIL-BASED CHEMOTHERAPY
    Nowara, E.
    Huszno, J.
    Butkiewicz, D.
    Kalinowska, M.
    Herok, K.
    Szoltysek, K.
    Drosik, K.
    Tecza, K.
    Pilat, J. Pamula
    ANNALS OF ONCOLOGY, 2010, 21 : 47 - 47
  • [6] P-Glycoprotein/MDR1 Regulates Pokemon Gene Transcription Through p53 Expression in Human Breast Cancer Cells
    He, Shengnan
    Liu, Feng
    Xie, Zhenhua
    Zu, Xuyu
    Xu, Wei
    Jiang, Yuyang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (09): : 3039 - 3051
  • [7] MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53
    CHIN, KV
    UEDA, K
    PASTAN, I
    GOTTESMAN, MM
    SCIENCE, 1992, 255 (5043) : 459 - 462
  • [8] mdr 1 expression and p53 mutations in breast cancer
    Vielh, P
    Lebeau, J
    Pouillart, P
    Chevillard, S
    LABORATORY INVESTIGATION, 1996, 74 (01) : 133 - 133
  • [9] MTHFR and MDR1 Gene Polymorphisms in Yakut Patients with Non-Syndromic Orofacial Clefts
    Diakonova, Aleksandra T.
    Pavlova, Nadezhda, I
    Alekseev, Vladislav A.
    Mironova, Lyubov S.
    Kurtanov, Khariton A.
    Dodokhov, Vladimir V.
    Ushnitsky, Innokenty D.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2021, 11 (04) : 576 - 580
  • [10] P53 expression and the result of adjuvant therapy of breast cancer
    Stal, O.
    Stenmark, Askmalm M.
    Wingren, S.
    Rutqvist, L.E.
    Skoog, L.
    Ferraud, L.
    Sullivan, S.
    Carstensen, J.
    Nordenskjold, B.
    Acta Oncologica, 34 (06):
12345